Molecular evidence for antigen-driven immune responses in cardiac lesions of rheumatic heart disease patients.
about
Strategies in the development of vaccines to prevent infections with group A streptococcusMolecular mimicry in the autoimmune pathogenesis of rheumatic heart disease.Genes, autoimmunity and pathogenesis of rheumatic heart disease.Rheumatic heart disease: proinflammatory cytokines play a role in the progression and maintenance of valvular lesions.Quantitative analysis of T cell receptor diversity in clinical samples of human peripheral blood.Rheumatic fever, autoimmunity, and molecular mimicry: the streptococcal connection.HLA class II DR and DQ genotypes and haplotypes associated with rheumatic fever among a clinically homogeneous patient population of Latvian children.Polymyositis-dermatomyositis and infections.Rheumatic heart disease: 15 years of clinical and immunological follow-upRheumatic fever and rheumatic heart disease: genetics and pathogenesis.CXCL9/Mig mediates T cells recruitment to valvular tissue lesions of chronic rheumatic heart disease patients.B- and T-cell responses in group a streptococcus M-protein- or Peptide-induced experimental carditis.Rheumatic Heart Disease: Molecules Involved in Valve Tissue Inflammation Leading to the Autoimmune Process and Anti-S. pyogenes Vaccine.Understanding rheumatic fever.Cellular and molecular mechanisms of autoimmune disease.T-cell reactivity against streptococcal antigens in the periphery mirrors reactivity of heart-infiltrating T lymphocytes in rheumatic heart disease patients.Association of angiotensin I-converting enzyme gene insertion/deletion polymorphism with rheumatic heart disease in Indian population and meta-analysis.Rheumatic fever: from innate to acquired immune response.TAP1-/- mice present oligoclonal BV-BJ expansions following the rejection of grafts bearing self antigens.T cell subsets: an integral component in pathogenesis of rheumatic heart disease.Acute rheumatic fever and rheumatic heart disease.
P2860
Q26863366-F81633AA-C3A3-46C3-883A-904B9080E514Q34491035-5801E862-2424-4080-AD27-8DB20BC884B5Q35015039-C262D157-306C-4E3B-854A-6C0F675EBB2EQ35103414-CAC8A125-1382-40BF-887E-4DB52C996552Q35661328-D9D34DDB-B290-4C70-8812-5B93621BA797Q36345906-9586ECA4-84AE-41BE-B0C8-FA5811055B09Q36392275-4F76642F-B1F6-4907-836E-8EE82729B399Q36504375-4253E49F-4BB2-41B4-AA1D-517EB877337AQ36596825-EC50140C-B3A0-40FA-9F36-3CB59BF91621Q36884512-B60D877D-C88D-4C83-B25F-078206251E32Q37002334-5B3CB3F1-EFD5-48E6-83CA-E323847E654EQ37191309-B042369A-EA18-4D24-8A30-B12D03C9BB9EQ37266703-208DE353-7D0B-4B5E-9A5A-0FB17C03CF76Q37939694-394B4A2E-BF3E-42EE-8F80-0400FB84A3F4Q37959331-1615BEA9-FC49-453F-B946-E96B347D6B90Q39521797-B8E1A56E-A859-4C0C-9D6C-C01AF9785713Q40244999-F18B7D44-8C00-485B-B610-D0B266EF74B1Q40440020-CB95971F-39C5-4971-ABBC-6C8CCE2EC6D4Q42594791-C76AE963-3548-454D-B7F7-21B50ABBE82AQ47369105-AF217315-8FDB-4246-81BA-A43D9A569F8DQ47429720-0ABBCE99-8FDB-4981-9CDB-EDC598C6672A
P2860
Molecular evidence for antigen-driven immune responses in cardiac lesions of rheumatic heart disease patients.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Molecular evidence for antigen ...... umatic heart disease patients.
@en
type
label
Molecular evidence for antigen ...... umatic heart disease patients.
@en
prefLabel
Molecular evidence for antigen ...... umatic heart disease patients.
@en
P2093
P2860
P356
P1476
Molecular evidence for antigen ...... eumatic heart disease patients
@en
P2093
A C Tanaka
E Cunha-Neto
L Guilherme
S E Oshiro
P2860
P304
P356
10.1093/INTIMM/12.7.1063
P577
2000-07-01T00:00:00Z